Bruce N. Barron

Bruce N. Barron is a founding partner of Origin Ventures. He is an observer to, or member of, the Boards of Directors of DialogTech, Archer Education, and Tock. He previously served on the GrubHub (NYSE: GRUB) Board of Directors. In addition, he serves on the boards of the American Cancer Society, the Chicago Baseball Cancer Charities, and Israel Cancer Research Fund Chicago and International Chapters. Bruce was named a Crain’s Chicago Business Tech 50 member in 2013. He also provides funding for the Origin Ventures Academy for Entrepreneurial Leadership at the University of Illinois.

From 1985-2007, Bruce was involved in the management of several start-up medical technology companies. From 1995-2007 he served as a member of the Board of Directors of Applied NeuroSolutions, Inc. (APNS), a public biotechnology company developing a diagnostic to detect, and therapeutics to treat, Alzheimer’s disease. He also served as CEO of APNS from 1995-2004, and as Chairman of the Board from 1999-2006. From 1988 to 2001 Bruce also served on the Board of Directors of Trimedyne Inc., a public manufacturer of surgical lasers used to treat diseases and other medical conditions.

Bruce received a B.S. degree in Accounting from the University of Illinois at Urbana-Champaign in 1977. He earned his C.P.A. certificate and worked as an accountant in the Chicago office of Touche Ross (the predecessor of Deloitte & Touche) and other medium-size public accounting firms. He left the practice of public accounting in 1985 to begin his entrepreneurial career. He enjoys traveling with his family.